CLDN1 and thyroid gland carcinoma: In case of thyroid cancer (Zwanziger et al., 2015) and NSCLC, overexpression (Jung et al., 2009; Sun et al., 2016) and extrajunctional mislocalization of Cldn1, with impact on cell–cell contacts and proliferation, is a specific hallmark.